These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
382 related articles for article (PubMed ID: 30192088)
1. Tardive dyskinesia risk with first- and second-generation antipsychotics in comparative randomized controlled trials: a meta-analysis. Carbon M; Kane JM; Leucht S; Correll CU World Psychiatry; 2018 Oct; 17(3):330-340. PubMed ID: 30192088 [TBL] [Abstract][Full Text] [Related]
2. Tardive Dyskinesia Prevalence in the Period of Second-Generation Antipsychotic Use: A Meta-Analysis. Carbon M; Hsieh CH; Kane JM; Correll CU J Clin Psychiatry; 2017 Mar; 78(3):e264-e278. PubMed ID: 28146614 [TBL] [Abstract][Full Text] [Related]
3. Effects of first-generation antipsychotics versus second-generation antipsychotics on quality of life in schizophrenia: a double-blind, randomised study. Gründer G; Heinze M; Cordes J; Mühlbauer B; Juckel G; Schulz C; Rüther E; Timm J; Lancet Psychiatry; 2016 Aug; 3(8):717-729. PubMed ID: 27265548 [TBL] [Abstract][Full Text] [Related]
4. Comparing the risk of tardive dyskinesia in older adults with first-generation and second-generation antipsychotics: a systematic review and meta-analysis. O'Brien A Int J Geriatr Psychiatry; 2016 Jul; 31(7):683-93. PubMed ID: 26679687 [TBL] [Abstract][Full Text] [Related]
5. A meta-analysis of the efficacy of second-generation antipsychotics. Davis JM; Chen N; Glick ID Arch Gen Psychiatry; 2003 Jun; 60(6):553-64. PubMed ID: 12796218 [TBL] [Abstract][Full Text] [Related]
6. One-year incidence rates of tardive dyskinesia in children and adolescents treated with second-generation antipsychotics: a systematic review. Correll CU; Kane JM J Child Adolesc Psychopharmacol; 2007 Oct; 17(5):647-56. PubMed ID: 17979584 [TBL] [Abstract][Full Text] [Related]
7. The CATIE and CUtLASS studies in schizophrenia: results and implications for clinicians. Naber D; Lambert M CNS Drugs; 2009 Aug; 23(8):649-59. PubMed ID: 19594194 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis. Zhang JP; Gallego JA; Robinson DG; Malhotra AK; Kane JM; Correll CU Int J Neuropsychopharmacol; 2013 Jul; 16(6):1205-18. PubMed ID: 23199972 [TBL] [Abstract][Full Text] [Related]
9. Relapse prevention in schizophrenia: a systematic review and meta-analysis of second-generation antipsychotics versus first-generation antipsychotics. Kishimoto T; Agarwal V; Kishi T; Leucht S; Kane JM; Correll CU Mol Psychiatry; 2013 Jan; 18(1):53-66. PubMed ID: 22124274 [TBL] [Abstract][Full Text] [Related]
10. Incidence of tardive dyskinesia with risperidone or olanzapine in the elderly: results from a 2-year, prospective study in antipsychotic-naïve patients. Woerner MG; Correll CU; Alvir JM; Greenwald B; Delman H; Kane JM Neuropsychopharmacology; 2011 Jul; 36(8):1738-46. PubMed ID: 21508932 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: comprehensive review of prospective head-to-head and placebo-controlled comparisons. Fraguas D; Correll CU; Merchán-Naranjo J; Rapado-Castro M; Parellada M; Moreno C; Arango C Eur Neuropsychopharmacol; 2011 Aug; 21(8):621-45. PubMed ID: 20702068 [TBL] [Abstract][Full Text] [Related]
12. Tardive dyskinesia in a South Asian population with first episode psychosis treated with antipsychotics. Adam UU; Husain N; Haddad PM; Munshi T; Tariq F; Naeem F; Chaudhry IB Neuropsychiatr Dis Treat; 2014; 10():1953-9. PubMed ID: 25342903 [TBL] [Abstract][Full Text] [Related]
13. Association With Hospitalization and All-Cause Discontinuation Among Patients With Schizophrenia on Clozapine vs Other Oral Second-Generation Antipsychotics: A Systematic Review and Meta-analysis of Cohort Studies. Masuda T; Misawa F; Takase M; Kane JM; Correll CU JAMA Psychiatry; 2019 Oct; 76(10):1052-1062. PubMed ID: 31365048 [TBL] [Abstract][Full Text] [Related]
14. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine. Krzystanek M; Krupka-Matuszczyk I Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416 [TBL] [Abstract][Full Text] [Related]
15. Long-term effectiveness of oral second-generation antipsychotics in patients with schizophrenia and related disorders: a systematic review and meta-analysis of direct head-to-head comparisons. Kishimoto T; Hagi K; Nitta M; Kane JM; Correll CU World Psychiatry; 2019 Jun; 18(2):208-224. PubMed ID: 31059621 [TBL] [Abstract][Full Text] [Related]
16. Incidence of tardive dyskinesia and tardive dystonia in African Caribbean patients on long-term antipsychotic treatment: the Curaçao extrapyramidal syndromes study V. van Harten PN; Hoek HW; Matroos GE; van Os J J Clin Psychiatry; 2006 Dec; 67(12):1920-7. PubMed ID: 17194270 [TBL] [Abstract][Full Text] [Related]
17. Tardive Dyskinesia and Long-Acting Injectable Antipsychotics: Analyses Based on a Spontaneous Reporting System Database in Japan. Misawa F; Fujii Y; Takeuchi H J Clin Psychiatry; 2022 Aug; 83(5):. PubMed ID: 35921512 [No Abstract] [Full Text] [Related]
18. Clinical risk factors for the development of tardive dyskinesia. Solmi M; Pigato G; Kane JM; Correll CU J Neurol Sci; 2018 Jun; 389():21-27. PubMed ID: 29439776 [TBL] [Abstract][Full Text] [Related]
19. Antipsychotics in adults with schizophrenia: comparative effectiveness of first-generation versus second-generation medications: a systematic review and meta-analysis. Hartling L; Abou-Setta AM; Dursun S; Mousavi SS; Pasichnyk D; Newton AS Ann Intern Med; 2012 Oct; 157(7):498-511. PubMed ID: 22893011 [TBL] [Abstract][Full Text] [Related]